Institutional Ownership Design Therapeutics, Inc. (DSGN)
This table provides information about the institutional ownership of Design Therapeutics, Inc. (DSGN). We have compiled data on the 96 institutions that hold shares in the stock, with a total of 33.6 Million shares, which have been reported (via 13F filing form) to have a value of $167 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Sr One Capital Management, LP
|
Aug 14, 2025 Q2 2025 |
6,526,476
shares
|
$32.5 Million
7.89% of portfolio
|
Q4 2022
Added 16.0%
|
|
Logos Global Management LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
4,217,627
shares
|
$21 Million
1.83% of portfolio
|
Q3 2024
Reduced 16.19%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,304,948
shares
|
$11.5 Million
0.0% of portfolio
|
Q2 2024
Added 1.35%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
1,953,547
shares
|
$9.73 Million
0.35% of portfolio
|
Q4 2024
Added 3.22%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Aug 14, 2025 Q2 2025 |
1,807,218
shares
|
$9 Million
0.01% of portfolio
|
Q2 2025
Reduced 0.59%
|
|
Tang Capital Management LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
1,780,975
shares
|
$8.87 Million
0.36% of portfolio
|
Q2 2025
Added 5.95%
|
|
Baker Bros. Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,712,882
shares
|
$8.53 Million
0.06% of portfolio
|
Q2 2025
Reduced 1.77%
|
|
Almitas Capital LLC
Santa Monica, CA |
Aug 14, 2025 Q2 2025 |
1,530,435
shares
|
$7.62 Million
2.43% of portfolio
|
Q2 2025
Added 5.34%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
1,471,574
shares
|
$7.33 Million
0.0% of portfolio
|
Q2 2025
Added 3.09%
|
|
Driehaus Capital Management LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
1,076,236
shares
|
$5.36 Million
0.04% of portfolio
|
Q2 2025
Added 17.83%
|
|
Kynam Capital Management, LP
Princeton, NJ |
Aug 14, 2025 Q2 2025 |
1,029,579
shares
|
$5.13 Million
0.41% of portfolio
|
Q2 2025
Added 13.89%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
840,793
shares
|
$4.19 Million
0.0% of portfolio
|
Q2 2025
Reduced 12.73%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
794,008
shares
|
$3.95 Million
0.0% of portfolio
|
Q2 2025
Added 2.39%
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
777,537
shares
|
$3.87 Million
0.01% of portfolio
|
Q2 2025
Added 20.42%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
719,212
shares
|
$3.58 Million
0.0% of portfolio
|
Q2 2025
Added 0.72%
|
|
Acadian Asset Management LLC
Boston, MA |
Aug 07, 2025 Q2 2025 |
627,348
shares
|
$3.12 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.57%
|
|
Bio Impact Capital LLC
Cambridge, MA |
Aug 14, 2025 Q2 2025 |
555,187
shares
|
$2.76 Million
0.37% of portfolio
|
Q2 2025
Reduced 1.38%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Aug 14, 2025 Q2 2025 |
390,648
shares
|
$1.95 Million
0.0% of portfolio
|
Q2 2025
Reduced 1.16%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
362,518
shares
|
$1.81 Million
0.0% of portfolio
|
Q2 2025
Reduced 2.98%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
313,363
shares
|
$1.56 Million
0.0% of portfolio
|
Q2 2025
Added 8.58%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
267,800
shares
|
$1.33 Million
0.0% of portfolio
|
Q2 2025
Added 1.06%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
250,949
shares
|
$1.25 Million
0.0% of portfolio
|
Q2 2025
Reduced 2.87%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
239,459
shares
|
$1.19 Million
0.0% of portfolio
|
Q2 2025
Reduced 9.98%
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
213,550
shares
|
$1.06 Million
0.0% of portfolio
|
Q2 2025
Reduced 13.85%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Aug 14, 2025 Q2 2025 |
188,200
shares
|
$937,236
0.02% of portfolio
|
Q2 2025
Added 65.38%
|